News

The ACTA was initiated in 2012 by the National Center for Advancing Translational Sciences (NCATS) through its Clinical and Translational Science Awards program in collaboration with representatives from several pharmaceutical companies to facilitate negotiations between institutional research sites and industry sponsors.

PPD has opened a central laboratory in Shanghai, China, to meet growing scientific and technical laboratory client demand for these services in China.

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it has received a project grant as part of a consortium.

The shift from volume- to performance-based payment is propelling life sciences companies to seek concrete data and medical evidence – both to understand patient care and to demonstrate the effectiveness, safety and value of drug therapies.

INC Research announced the formation of a new Site Advocacy Group (SAG) under the auspices of its relationship with the Society for Clinical Research Sites (SCRS).

Quintiles announced a strategic alliance with Hospital Italiano of Buenos Aires as part of the company’s Prime Site program.

ERT announced the launch of the Insights Cloud™, a suite of data analytics, visualization, and workflow applications.

New faces among the Pharma Industry rise the ranks.

Figure 1: The Problem 

While some countries are more progressive in approaching this challenge by virtue of mandatory, free of charge, molecular testing on all patients, this varies greatly in other countries based on institutional policy and insurance reimbursement.

Clinipace Worldwide has announced the takeover of Accovion, a CRO with a head office in Frankfurt (Eschborn), Germany.

Accovion Strengthens Clinipace’s Operational and Therapeutic Expertise Within Europe

Researchers at the University of Manchester and Central Manchester University Hospitals NHS Foundation Trust (CMFT) have published new data about public knowledge of, and interest in, the process of medicines R&D.

ArisGlobal, a leading provider of solutions to the life sciences industry, has today announced the availability of agFileMaster; a Cloud-based electronic trial master file.

The team behind Clinical Conductor CTMS recently debuted new functionality that allows healthcare organizations to better manage adaptive and dynamic clinical research that is becoming more relevant in the industry every year.

Three new academic programs have been added to the PAREXEL Academy which span the globe and are designed to prepare students for careers in the biopharmaceutical industry.

Survey shows what keeps Ukrainians away from clinical trials

The use and number of cognitive-enhancing drugs is likely to grow substantially in the coming years, and researchers must prioritize the potential advantages and dangers of their use in healthy subjects, according to U.K. neuroscientists writing in The Lancet Psychiatry journal.